awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853072-241D2390-4314-45B2-A890-C675D430D1A5
Q27853072-241D2390-4314-45B2-A890-C675D430D1A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853072-241D2390-4314-45B2-A890-C675D430D1A5
Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib
P2860
Q27853072-241D2390-4314-45B2-A890-C675D430D1A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853072-241D2390-4314-45B2-A890-C675D430D1A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
838562c53e6a22429c67a43850202de1a2a60fce
P2860
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.